Neurocrine Biosciences: A Biotech Balancing Stable Growth with a Bold, Risky Bet
Trouble Brewing? Soleno Therapeutics Under the Microscope
A Crushing Blow: Acadia Pharma's Prader-Willi Syndrome Trial Fails to Meet Endpoints
Tragic Loss in Vyfat XR Trial Casts Shadow on Soleno Therapeutics